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Abstract
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Background—An issue of critical importance for psychiatry and women’s health is whether
postpartum depression (PPD) represents a unique condition. The Diagnostic and Statistical
Manual of Mental Disorders asserts that major depressive disorder (MDD) may present with
peripartum onset, without suggesting any other differences between MDD and PPD. The absence
of any distinct features calls into question the nosologic validity of PPD as a diagnostic category.
The present study investigates whether symptom profiles differ between PPD and depression
occurring outside the postpartum phase.
Methods—In a prospective, longitudinal study of parturient women (N=239), we examine the
manifestation of depression symptoms. We assess factor structure of symptom profiles, and
whether factors are differentially pronounced during and after the postpartum period.

Author Manuscript

Results—Factors were revealed representing: Worry, Emotional/Circadian/Energetic
Dysregulation, Somatic/Cognitive, Appetite, Distress Display, and Anger symptoms. The factor
structure was validated at postpartum and after-postpartum timepoints. Interestingly, the Worry
factor, comprising anxiety and guilt, was significantly more pronounced during the postpartum
timepoint, and the Emotional/Circadian/Energetic Dysregulation factor, which contained sadness
and anhedonia, was significantly less pronounced during the postpartum period.
Conclusions—These results suggest that PPD may be a unique syndrome, necessitating
research, diagnosis, and treatment strategies distinct from those for MDD. Results indicate the
possibility that worry is an enhanced feature of PPD compared to depression outside the
postpartum period, and the crucial role of sadness/anhedonia in MDD diagnosis may be less
applicable to PPD diagnosis.
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1. INTRODUCTION
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Depression conveys the greatest burden of any disease in the U.S. (C. J. Murray et al., 2013),
and represents a unique public heath challenge due to the combined effects of its ubiquity,
heterogeneity, bio-socio-psychological complexity, and the suffering it imposes on
individuals, families, and communities. One of the most frequent yet understudied
precipitators of depression is childbearing. It has been estimated that globally, 1 in 8 new
mothers suffers from postpartum depression (PPD) (O’Hara & Swain, 1996). PPD inflicts an
exceptionally pernicious impact because it poses serious threats to the well-being of both the
mother (Goodman, 2007; O’Hara, 2009) and child. Infants of mothers suffering from PPD
exhibit higher mortality rates and lifelong cognitive, social, and health detriments
(Goodman, 2007; L. Murray et al., 2011; Verbeek et al., 2012).

Author Manuscript

Despite the high incidence and personally damaging repercussions of PPD, it is not known
whether PPD represents a distinct syndrome from major depressive disorder (MDD)
occurring outside the peripartum period (Bernstein et al., 2008; Hendrick, Altshuler, Strouse,
& Grosser, 2000). As a result, we are severely limited in our ability to recognize or intervene
in this devastating mental illness. Here, we address this major lacuna in our understanding of
depression during the peripartum phase. Our approach focuses on symptom clustering and
differential manifestation of particular symptom constellations in response to childbearing to
determine the validity of PPD as a diagnostic category.

Author Manuscript

Whether PPD is different from MDD is a question of scientific and clinical relevance. In
order to resolve its diagnostic status, it must be determined whether PPD has
psychobiological mechanisms of risk, etiology, or manifestation that are unique from those
of MDD. It is plausible to expect that PPD etiology is distinct from etiology of depression
occurring outside the perinatal phase because endocrine regulation of mood has been
implicated in a wide range of psychopathologies (Taylor, Maloney, Dearborn, & Weiss,
2009) and pregnancy involves endocrine fluctuations that are unparalleled in magnitude
compared to the rest of the lifespan, even puberty and menopause (Tulchinsky & Little,
1994). Strong evidence from animal models and emerging evidence from human research
suggests that pregnancy induces profound alterations to maternal brain structure and
function (Glynn, 2010; Glynn, Davis, Sandman, & Goldberg, 2016; Yim et al., 2009). The
distinctive endocrine experience and exceptional neuroplasticity associated with pregnancy
justify the hypothesis that PPD may have distinct etiologic characteristics compared to
depression occurring during other life phases.
Furthermore, PPD and MDD are associated with different neurobiological profiles. Women
with PPD exhibit hypoactive resting-state neural activity in cortical and subcortical limbic
regions compared with non-PPD mothers, while non-perinatal MDD men and women
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exhibit hypoactive resting-state neural activity in lateral brain regions and resting-state
hyperactivity in medial affective and subcortical limbic regions compared with non-MDD
individuals (reviewed in (Pawluski, Lonstein, & Fleming, 2017)). PPD and MDD are also
associated with divergent activation profiles in response to non-infant emotional cues.
Women with PPD exhibit lower activation in the amygdala and striatum (Barrett et al., 2012;
Moses-Kolko, Horner, Phillips, Hipwell, & Swain, 2014), and individuals with MDD exhibit
higher activation in the amygdala and striatum (Drevets, 2000; Phillips, Drevets, Rauch, &
Lane, 2003). These differences in brain resting-state and activation profiles suggest that PPD
could be a condition etiologically distinct from MDD, or have distinct characteristics.

Author Manuscript
Author Manuscript

The National Institutes of Mental Health (NIMH) recently instituted the Research Domain
Criteria (RDoC) project in response to the limitations traditional diagnostic categories
impose on the study of mental illness (Cuthbert & Insel, 2013). Our study design is
compatible with the RDoC emphases on dimensionality and deconstruction of
heterogeneous diagnostic categories (e.g., MDD) into fundamental components. In terms of
dimensionality, we utilize a continuous scale measurement of each depressive symptom
rather than the traditional binary medical approach, i.e., “depressed” versus “not depressed.”
Exploring the essence and constitution of PPD requires a gradient quantitative analysis as a
precondition of developing binary systems of participant recruitment and statistical analysis.
In terms of deconstructing heterogeneous diagnostic categories into fundamental
components, we assert that symptom-based approaches are necessary for clarifying how we
define and classify mental illnesses (Calamari, Wiegartz, & Janeck, 1999) in order to
identify biomarkers and genetic risk factors, and evaluate treatment efficacy (Bech, 2006;
Fried & Nesse, 2015). For depression research, this necessity is born out in evidence that
specific symptoms, compared with threshold scores, have demonstrated stronger
relationships with allelic variants (Kendler, Aggen, & Neale, 2013; Myung et al., 2012),
inflammatory (Duivis, Vogelzangs, Kupper, de Jonge, & Penninx, 2013) and hormone
profiles (Lamers et al., 2013), and antidepressant responses (Dew et al., 1997). Subtyping of
depression has been based upon symptom profiles (e.g., atypical), precipitating causes (e.g.,
seasonal affective disorder), or both (Keller & Nesse, 2006). This study will inform our
understanding of whether the precipitating event of childbirth justifies a depression subtype
or distinct syndrome based on symptom profiles, beyond just a precipitating event specifier
(viz. Diagnostic and Statistical Manual of Mental Disorders (DSM)-5). While the PPD
acronym may refer to either perinatal or postpartum depression, here we utilize the latter
terminology because our timepoint of interest is during the postpartum phase.

Author Manuscript

Despite the necessity and benefits of symptom-based approaches for diagnosing and
studying depression, many studies use categories based on depression rating scale sum score
cutoffs, which amalgamate individuals into one undifferentiated classification. This
procedure is based on the erroneous suppositions that depression is a monolithic syndrome,
and all symptoms are interchangeable and contribute equivalently to diagnostic classification
(Fried & Nesse, 2015). Psychometrically validated instruments that are used to assess
depression in clinical research utilize the sum of self-reported Likert-scale assessments, with
a threshold cutoff score for classifying individuals as depressed. The use of sum scores and
cutoff thresholds imposes three major impediments to research. Firstly, a sum score reveals
no information about symptomology, and this loss of information impairs the interpretability
Depress Anxiety. Author manuscript; available in PMC 2019 April 01.
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of the score. Secondly, cutoff thresholds treat all symptoms as having equivalent importance
for diagnosis. This practice is contrary to the diagnostic criteria of the DSM and
International Statistical Classification of Diseases (ICD), which highlight certain symptoms
as necessary and others as ancillary (Table 2). Myriad combinations of symptom
endorsements and severities can result in scores above the threshold. Thirdly, cutoff
thresholds result in loss of the dimensionality that is valuable for statistically modeling
depression’s relationships with risk factors and consequences.

Author Manuscript

We posit the widely-held assumption of PPD’s symptomatic similitude with MDD along
with the wide use of sum score cutoffs to study PPD may have obfuscated unique aspects of
perinatal mood dysregulation that could prove crucial for discerning the etiology of this
ubiquitous form of mental illness. We therefore aim to discern whether depressive symptom
constellations manifest differently during the postpartum phase compared with years later.
We use a dimensional approach by measuring symptomology in the full cohort, and also
repeat all analyses for the subset of women who meet traditional research study criteria for
at least minor depression (Martens et al., 2006; S Matthey, Henshaw, Elliott, & Barnett,
2006), for the subset of women who did not use anti-depressant medications at the
postpartum timepoint, and for the subsets of women who were and were not breastfeeding at
the postpartum timepoint.

2. METHODS
2.1. Cohort and procedure

Author Manuscript

Study participants were 239 women participating in a longitudinal study on mother-child
psychobiology and development at a university in California. Women were enrolled during
early pregnancy if they met eligibility criteria of singleton pregnancy, English-speaking,
non-smoking, age 18+, without use of steroid medications, drug or alcohol use during
pregnancy. The study was conducted in compliance with the Code of Ethics of the World
Medical Association and the Declaration of Helsinki. The protocol was approved by the
institutional review boards of participating universities. All participants provided written,
informed consent after receiving a complete description of study procedures.

Author Manuscript

To compare depression during postpartum and non-peripartum life-phases, we identified two
timepoints in our protocol from which to draw data. We determined the timing of the
postpartum phase by taking into consideration the inconsistent literature on this subject
(Wisner, Moses-Kolko, & Sit, 2010), which has defined postpartum as spanning from
parturition through 1-month (American_Psychiatric_Association, 1994), 1.5-months
(World_Health_Organization, 2016), 6-months (Miller, 2002; Viguera et al., 2011) and 12months afterwards (Munk-Olsen, Laursen, Pedersen, Mors, & Mortensen, 2006). PPD onset
can occur at any time across several months after parturition (Stowe, Hostetter, & Newport,
2005), with peak phase of vulnerability at 3-months (Elliott, 2000; Munk-Olsen et al., 2006).
Accordingly, we selected the assessment occurring 3-months after parturition to represent
the “postpartum” timepoint, and the assessment occurring 24-months after parturition to
represent the “after-postpartum” timepoint. Analyses herein compare depression symptom
profiles assessed at these two timepoints. Participants were excluded if they had another
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pregnancy during the 24-month follow-up period (N=36). Details about the cohort are
presented in Table 1.
2.2. Symptoms of depression

Author Manuscript

Our first step towards investigating the symptom profiles of PPD was compiling a
comprehensive list of 53 depression symptoms based on authoritative sources (Table 2).
Because the larger, longitudinal study of mother-child psychobiology was not designed with
the present approach in mind, not all depression symptoms had a corresponding item. From
the full list of possible symptoms, we found corresponding items by searching through the
instruments administered in our longitudinal study, selecting items that were administered at
both the postpartum and after-postpartum timepoints. The selection of items was discussed
and refined by a group of clinical and academic researchers representing several academic
disciplines, including Psychology, Psychiatry, and Biological Anthropology. Ultimately,
selected items were agreed to reflect 21 symptoms of depression (Table 2).
2.3. Statistical methods
Data were unitized so each symptom scaled 0–1, where 0 is the lowest and 1 is the highest
possible score even if those ends of the scale were not endorsed. The full cohort at the
postpartum timepoint was randomly split into two subsets, Cohort-Half-1 and CohortHalf-2, in order to perform exploratory factor analysis (EFA) on one half and confirmatory
factory analysis (CFA) on the other half as a cross-validation of the determined factor
structure. The groups did not significantly differ on socio-demographic or health-related
traits, with the exception of number of obstetric risk factors (Table 1).

Author Manuscript

EFA was conducted on Cohort-Half-1 to assess whether particular symptoms segregate
together to produce clusters in depression symptomology during the postpartum period. EFA
was performed using psych, nFactors, and GPArotation packages for R. Kaiser’s eigenvalue
criterion (Kaiser, 1960), parallel analysis (Horn, 1965), and Raiche’s optimal coordinates
approach (Raîche, Walls, Magis, Riopel, & Blais, 2013) all suggested extracting 6 factors
(Supporting Information Figure S1). The average residuals for the correlation matrix (root
mean square of residuals) of the 6-factor model was 0.04, indicating excellent fit. These
criteria converged to support the retention of 6 factors from the dataset.
Maximum Likelihood (ML) estimation was selected for factor extraction, because it
estimates the level of shared variance for each item, and it has been shown experimentally to
produce more generalizable and reproducible results than other methods (Osborne &
Costello, 2009). The retained factors were rotated obliquely using a minimizing criterion.

Author Manuscript

Confirmatory factor analysis (CFA) was conducted to assess the stability of the factor
structure suggested by EFA in three analyses. (1) CFA assessed the factor structure stability
at the postpartum timepoint in Cohort-Half-1 and Cohort-Half-2. (2) CFA assessed the fit of
the determined factor structure using the same cohort’s responses to the same items at the
after-postpartum timepoint. (3) CFA was conducted on the subset of women (N=86) who
met traditional research study criteria for at least minor depression at the postpartum
timepoint (Table 1) (Irwin, Artin, & Oxman, 1999), and on the subset of women (N=229)
who did not use anti-depressant medications at the postpartum timepoint (Table S3).
Depress Anxiety. Author manuscript; available in PMC 2019 April 01.
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Insufficient sample size prevented us from conducting separate analyses on the subset of
women who met traditional criteria for major depression (N=20). For CFA analyses, we
used the lavaan package for R, and assessed whether Heywood cases were detected based on
error variances and squared multiple correlations (SMCs) for each item. We inspected
standardized residual correlation tables, modification indices, and fit indices.

Author Manuscript

We assessed whether the prevalences of symptom clusters differ meaningfully between the
postpartum and after-postpartum timepoints by measurement invariance modelling (using
the semTools package for R) and paired t-tests. For paired t-tests, in order to avoid any
influence from attrition in participation, after confirming the likelihood that data were
missing at random within identifiable strata (Heitjan & Basu, 1996), we used multivariate
imputation by chained equations (Azur, Stuart, Frangakis, & Leaf, 2011; Buuren &
Groothuis-Oudshoorn, 2011), utilizing women’s demographic characteristics, obstetric
history, marital and cohabitation status with the baby’s father, and depressive symptoms
measured at 6-months and 12-months postpartum to impute missing symptom scores at 24months postpartum (N=112) using predictive mean matching (PMM). PMM assures imputed
values are plausible, and is robust for non-normally distributed data (Horton & Lipsitz,
2001). We followed standard procedure in which missing values are replaced with
predictions derived from regression models over 10 cycles (Raghunathan, Solenberger, &
Van Hoewyk, 2002), repeating this entire process 5 times (Graham, Olchowski, & Gilreath,
2007). T-test results were pooled (Harel & Zhou, 2007).

Author Manuscript

To validate the results obtained with the above procedures, we also employed a secondary
methodology. Linear mixed effects models were fit by restricted maximum likelihood
estimation (Verbeke & Molenberghs, 2009) with random intercepts for individual identity to
assess the relation between symptom factor scores and timepoints. To describe results, we
report pooled Pearson product-moment correlations between scores at the postpartum and
after-postpartum timepoints for the factors. Analyses of imputed data utilize R packages
Amelia, mice, and miceadds.

3. RESULTS

Author Manuscript

Results of the EFA indicated face validity of the resulting factor structure, with symptom
clusters that had clinical meaning (Table 3). Factor 1 reflected a “Worry” cluster, consisting
of anxiety and guilt. Factor 2 reflected an “Anger” symptom cluster. Factor 3 contained
several items such as anhedonia, inability to stay asleep, and fatigue, and was deemed
“Emotional/Circadian/Energetic Dysregulation.” Factor 4 reflected “Appetite.” Factor 5
included “Somatic/Cognitive” items. Factor 6 consisted of items that reflect the behavioral
expression of negative affectivity, so we deem it “Distress display.”
Results of the EFA were highly parsimonious, with only one symptom loading at the 0.3
threshold onto more than one factor (Table 3). “Anger” loaded at 0.46 onto Factor 2 and .30
onto Factor 3, so the Factor with the higher loading was selected for this item. Because of
the simple structure of our results, only the loading of each item on its respective factor are
displayed. “Pessimism” and “Negative reactivity” had no loadings above 0.30, so were not
included in the factor structure.
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Results suggested no differences in symptom segregation profiles between the two random
halves of the cohort at the postpartum timepoint. CFA supported the 6-factor model derived
from the EFA as a good fit for the data in both Cohort-Half-1 and Cohort-Half-2. All fit
indices indicated superior fit for the 6-factor compared with the null (one-factor) model
(Table 4) and SMCs were higher in the 6-factor compared with the null model (M=0.2
higher for Cohort-Half-1, M=0.1 higher for Cohort-Half-2, Supporting Information Table
S1).

Author Manuscript
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Results suggested no differences in how symptoms segregate between the postpartum and
after-postpartum timepoints. We claim the same factor structure holds across timepoints
based on achievement of configural, metric, and scalar invariance (Meredith, 1993;
Vandenberg & Lance, 2000). For configural invariance, CFA supported the 6-factor model
derived from the EFA as a good fit for the data at the after-postpartum timepoint. All fit
indices indicated superior fit for the 6-factor compared with the null model (Table 4) and
SMCs were higher in the 6-factor compared with the null model (M=0.1 higher, Supporting
Information Table S1). Configural invariance indicates that the same pattern of relationships
between indicators and latent variables holds across timepoints. Metric invariance suggests
that in addition to latent variables measured by the same indicators, factor loadings are
equivalent across administrations. For metric invariance (Supporting Information Table S4),
chi-square change between the configural and metric models is nonsignificant (p=0.12)
indicating that factor loadings are invariant across timepoints. For scalar invariance
(Supporting Information Table S4), chi-square change between the metric and scalar models
is nonsignificant (p=0.36) indicating that item intercepts are equivalent across timepoints.
Configural, metric, and scalar invariance justify comparison of factor means across
timepoints. The model did not exhibit strict invariance (chi-square p<0.00, Supporting
Information Table S4), indicating variance in residual variances across timepoints, but strict
invariance is highly constrained and rarely achieved in practice (Bialosiewicz, Murphy, &
Berry, 2013; Millsap & Meredith, 2007).
The same symptom profile structure also robustly applied to the subset of data from women
who met traditional depression criteria at the postpartum timepoint (Table 1). CFA supported
the 6-factor model derived from EFA as a good fit for the data for women above the
traditional cutoff thresholds for at least minor depression at the postpartum timepoint. All fit
indices indicated superior fit for the 6-factor compared with the null model (Table 4) and
SMCs were higher in the 6-factor compared with the null model (M=0.1 higher, Supporting
Information Table S1). The same symptom profile structure also robustly applied to the
subsets of women who did not use antidepressant medications, and those who were and were
not breastfeeding at the postpartum timepoint (Supporting Information Table S3).

Author Manuscript

Two particular symptom factors exhibited meaningful differences in prevalence between the
postpartum and after-postpartum timepoints (Figure 1). Pairwise t-tests revealed that
“Worry” scores were more pronounced during the postpartum timepoint, compared with the
after-postpartum (t(241)=(1.84,2.63), M of differences=0.04, p=0.03), and “Emotional/
Circadian/Energetic Dysregulation” scores were less pronounced during the postpartum
timepoint, compared with the after-postpartum (t(241)=(−4.71,−1.26), M of differences=
−0.01, p=0.03). These results were further validated using a different method of analysis.
Depress Anxiety. Author manuscript; available in PMC 2019 April 01.

Fox et al.

Page 8

Author Manuscript

Mixed-effects models supported our calculation that “Worry” scores were more pronounced
during the postpartum timepoint (β=0.03, p=0.08), and “Emotional/Circadian/Energetic
Dysregulation” scores were less pronounced during the postpartum timepoint (β=−0.03,
p=0.04) (Supporting Information Table S2).

Author Manuscript

Among the subset of women who met traditional research study criteria for at least minor
depression at the postpartum timepoint, “Worry” and “Emotional/Circadian/Energetic
Dysregulation” scores differed meaningfully between the two timepoints. Pairwise t-tests
confirmed that “Worry” scores were more pronounced during the postpartum timepoint,
compared with the after-postpartum (t(85)=(3.44,4.36), p<0.00). “Emotional/Circadian/
Energetic Dysregulation” scores exhibited no significant difference between the two
timepoints. It should be noted that subsetting the cohort based on traditional research criteria
cutoff for minor depression is redundant with “Emotional/Circadian/Energetic
Dysregulation” scores (logistic regression χ2=20.1, p<0.00, Nagelkerke’s R2=0.7), so
differences between timepoints would not be expected.

4. DISCUSSION

Author Manuscript

Depression symptom profiles are known to vary between individuals, as well as within
individuals over time (Oquendo et al., 2004). Here, we address the question of whether
depression occurring during the postpartum phase is characterized by a unique symptom
profile, compared with depression outside the postpartum phase. In a longitudinal cohort of
239 women assessed at postpartum (3-months after parturition) and after-postpartum (24months after parturition) timepoints, we conducted exploratory factor analyses of individual
symptoms to investigate whether particular symptoms are more likely to present together,
confirmatory factor analysis and longitudinal invariance modelling (Meredith, 1993;
Vandenberg & Lance, 2000) to investigate whether the segregation of these symptoms
differs between the two timepoints, and t-tests to investigate whether symptom cluster
prevalence varies between timepoints. Results suggest that the structure of symptom profiles
is not different between the postpartum and after-postpartum timepoints, but the prevalence
of two particular symptom clusters differs. “Worry” is more pronounced during the
postpartum, and “Emotional/Circadian/Energetic Dysregulation” is less pronounced during
the postpartum. Our observation that PPD may have a symptomatic signature that is distinct
from depression during other life phases is consistent with the possibility that depression
occurring during the perinatal phase of life is a condition separate from MDD, or a condition
with unique characteristics.

Author Manuscript

We found that the Worry symptom cluster was the most pronounced at the postpartum
timepoint (Figure 1), and was a hallmark differentiating depression profiles at the
postpartum compared with the after-postpartum timepoint. These results were validated (and
even stronger) among the subset of women who met traditional research criteria for at least
minor depression. The Worry symptom cluster comprises anxiety and guilt. While previous
studies have not assessed symptomology using multiple instruments, previous studies have
recognized anxiety as a distinctive feature of PPD (Stephen Matthey, Barnett, Howie, &
Kavanagh, 2003), with multiple reports that postpartum depressed women exhibit enhanced
anxiety symptoms (C. T. Beck & Indman, 2005; Hendrick et al., 2000). Two studies
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conducting principal components analysis with the EPDS have found that the three anxietyrelated items comprise a distinct subscale (Brouwers, van Baar, & Pop, 2001; L. Ross, S. G.
Evans, E. Sellers, & M. Romach, 2003). Furthermore, the 3-item EPDS anxiety subscale
exhibits strong validity as a predictor of overall EPDS score (Kabir, Sheeder, & Kelly, 2008).
A cross-sectional study comparing pregnant and postpartum women using anxiety,
depressed mood, and anhedonia EPDS sub-scales (Stephen Matthey, Fisher, & Rowe, 2013;
L. E. Ross, S. G. Evans, E. Sellers, & M. Romach, 2003; Tuohy & McVey, 2008) found that
anxiety and anhedonia were more likely to have postpartum rather than antepartum onset
(Putnam et al., 2017). Another cross-sectional study found enhanced worthlessness/guilt in
pregnant compared with non-peripartum women (Hoertel et al., 2015).

Author Manuscript

We found that prevalence of “Emotional/Circadian/Energetic Dysregulation,” the symptom
factor that contains sadness, anhedonia, and psychomotor retardation among other
symptoms, was significantly lower during the postpartum compared with the afterpostpartum timepoint (Figure 1). In other words, women exhibited less emotional/circadian/
energetic dysregulation, during the postpartum compared with the after-postpartum
timepoint. One previous study observed among postpartum women the sadness symptom
exhibited significantly weaker correlation with overall depression than it did among nonpostpartum women (Bernstein et al., 2008). Further, the only previous study known to us
comparing postpartum and non-postpartum depression symptomology documented that
psychomotor symptoms were relatively reduced among the postpartum cohort, and that this
was true for women both with and without a clinical diagnosis of depression (Hoertel et al.,
2015). These findings parallel our observation that the factor containing psychomotor
retardation was reduced during the postpartum in women who did and did not meet the
threshold for minor depression.

Author Manuscript

As expected, among the subset of women who met traditional research criteria for at least
minor depression, no differences in prevalence of “Emotional/Circadian/Energetic
Dysregulation” between the timepoints were revealed. Traditional research instruments for
assessment of depression rely heavily on symptoms contained in this factor, so “Emotional/
Circadian/Energetic Dysregulation” scores statistically behave as a close surrogate for the
cutoff criterion itself.

Author Manuscript

Given the principal role of sadness/anhedonia in diagnostic determination of MDD
(American_Psychiatric_Association, 2003), our observation that a distinguishing feature of
depression during the postpartum phase is lower prevalence of emotional/circadian/energetic
dysregulation supports the case for different diagnostic criteria to identify MDD and PPD.
For example, the DSM-5 requires either depressed mood or loss of interest to contribute
towards five or more symptoms to diagnose MDD (American_Psychiatric_Association,
2003). If Worry is, instead, the most pronounced feature of PPD, then it could be efficacious
to consider diagnostic criteria for PPD that emphasize Worry symptoms, rather than
necessitating presence of depressed mood or loss of interest.
Despite the theoretical supposition from evolutionary anthropology that social signals of
distress might be a key feature of PPD (Hagen, 1999), we observed no overrepresentation of
“Distress Display” (the symptom factor that includes crying, sad affect display, and thoughts
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of self-harm) in our data. We found no significant differences in prevalence of this factor
between the postpartum and after-postpartum timepoints (Figure 1). Previous authors have
described similar observations in this regard. One study of PPD symptomology found that
the symptoms with the five lowest prevalence scores were all related to suicidal thoughts (C.
T. Beck & Indman, 2005), another found that postpartum women exhibited less suicidal
thoughts than non-postpartum women (Bernstein et al., 2008), and another observed less
suicidality in postpartum compared with non-peripartum women (Hoertel et al., 2015).
Future evolutionary frameworks for understanding the potential function or selective
consequences of PPD should consider the symptom profiles that characterize the condition.

Author Manuscript

Determining whether PPD is a distinct syndrome from MDD has important implications for
public health surveillance as well as designing and assessing prevention strategies and
treatment practices. Hendrick et al. found differences in treatment efficacy for depression
among postpartum compared with non-postpartum women (Hendrick et al., 2000).
Postpartum women exhibited longer time to response for pharmacological treatment, and
greater need to be on two or more antidepressant agents to achieve response. Beck and
Indman suggest that “[c]linicians need to be cognizant of the fact that anxiety and not
depression may be the presenting symptom of mothers suffering from postpartum
depression” (C. T. Beck & Indman, 2005). In this vein, an important question for future
research will be to determine how anxiety in the postpartum period may differ from that
characterizing generalized anxiety disorder or anxiety manifesting outside of the peripartum
period.

Author Manuscript

A major strength of this investigation is the longitudinal study design and the broad
characterization of depressive symptoms, which allows us to observe each postpartum
woman compared to herself during a later life-phase. This life-course, trajectory approach to
investigating depressive symptomology is unprejudiced by bias or random differences
between cohorts. A limitation of the study is that we are not able to compare these results to
a non-perinatal cohort. However, we were able to ensure no pregnancies or miscarriages over
a two-year period in an adult female cohort, which would pose logistical challenges if a
cross-sectional comparison cohort were sought. Another limitation is the latest afterpostpartum timepoint we were able to assess in this study is two-years-post-parturition, and
future studies are needed to confirm that two years is sufficiently representative of
depressive symptoms not associated with perinatal experiences. Future studies with a larger
sample size of individuals followed across a longer time scale are needed to validate our
findings.

Author Manuscript

5. CONCLUSION
Our results suggest that PPD has a symptomatic signature involving greater prevalence of
Worry and lower prevalence of Emotional/Circadian/Energetic Dysregulation. This
observation is consistent with the possibility that PPD represents a unique syndrome from
MDD occurring outside the perinatal phase. Future studies should compare psychobiological
mechanisms of symptom manifestation in PPD and MDD to further investigate the validity
of these diagnostic categories.
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Figure 1.
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Differences in symptom cluster prevalences between the postpartum and after-postpartum
timepoints. Results suggest that the “Worry” factor is more prevalent during the postpartum
compared with the after-postpartum timepoint, and the “Emotional/Circadian/Energetic
Dysregulation” factor is less pronounced during the postpartum compared with the afterpostpartum timepoint. Pooled Pearson product-moment correlations between timepoints:
factor 1 r=0.49, p<0.00***; factor 2 r=0.27; p=0.01**; factor 3 r=0.24, p=0.01*; factor 4
r=0.48, p<0.00***; factor 5 r=0.62, p<0.00***; factor 6 r=0.12, p=0.11.

Author Manuscript
Depress Anxiety. Author manuscript; available in PMC 2019 April 01.

Author Manuscript

Author Manuscript

Author Manuscript
30.4 (5.4)
63046.2 (33072.1)
39.1 (2.1)
3386.3 (586.8)

10 (8.4)
41 (34.5)

29.9 (5.5)
61276.2 (33872)
39.1 (2.1)
3373.9 (579.2)
3.6 (2.9)
5.4 (4.5)
82 (34.3)
50 (20.9)
20 (8.4)
86 (36)

Maternal age at delivery (yrs, mean (SD))

Household income before taxes (US$, mean (SD))

Gestational week at delivery (wks, mean (SD))

Birth weight (g, mean (SD))

CESD-SFb score (mean (SD))

EPDSc score (mean (SD))

Above depression cutoff threshold for CESD-SF d (N (%))

Above minor depression cutoff threshold for EPDSe (N (%))

Above major depression cutoff threshold for EPDSe (N (%))

Above any depression cutoff threshold (N (%))

Depress Anxiety. Author manuscript; available in PMC 2019 April 01.

Less than high school

Maternal education (N (%))
7 (2.9)

12 (5)

8 (3.3)

After-postpartum

History of mental illnessg (N (%))

10 (4.2)

Postpartum

Antidepressant medication f (N (%))

119

239

N

2 (1.7)

6 (5)

2 (1.7)

6 (5)

23 (19.3)

38 (31.9)

5.3 (4.2)

3.5 (2.8)

Cohort Half 1

Full cohort

5 (4.2)

6 (5)

6 (5.0)

4 (3.3)

45 (37.5)

10 (8.3)

27 (22.5)

44 (36.7)

5.5 (4.7)

3.6 (3)

3361.5 (573.7)

39.1 (2)

59520.8 (34696)

29.5 (5.5)

120

Cohort Half 2

ns

4 (4.7)

10 (11.6)

8 (9.3)

Xsq=4.4 *
ns

10 (11.6)

86 (100)

20 (23.3)

50 (58.1)

82 (95.3)

9.7 (4.1)

6.8 (1.7)

3412.4 (613.3)

38.8 (2.3)

53488.4 (33237.7)

29.5 (5.9)

86

Depressed subset

ns

ns

ns

ns

ns

ns

ns

ns

ns

ns

ns

ns

Half 1 vs Half 2a

ns

Xsq=3.9+

ns

Xsq=11.0 ***

Xsq=233.7 ****

Xsq=35.9 ****

Xsq=109.0 ****

Xsq=220.0 ****

t=13.9 ****

t=23.3 ****

ns

t=−1.8 +

t=−2.7 **

ns

ns

Euthymic vs Depresseda

Descriptive statistics, separated by the random partitioning for statistical tests (“Half 1” and “Half 2”), and the subset of the full cohort who meet
traditional criteria for depression

Author Manuscript

Table 1
Fox et al.
Page 17

Author Manuscript
97 (40.6)
65 (27.2)
41 (17.2)
1 (0.4)

Bachelors degree

Graduate degree

NA

63 (26.4)
31 (13)
22 (9.2)
8 (3.3)
4 (1.7)

Hispanic

Multi-ethnic

Asian

African-American

Other or NA

216 (90.4)

Yes

Depress Anxiety. Author manuscript; available in PMC 2019 April 01.
141 (59)
96 (40.2)
29 (12.1)
13 (5.4)
3 (1.3)

Parous (all)

Parous, 1 previous delivery

Parous, 2 previous deliveries

Parous, 3 previous deliveries

Parous, 4 previous deliveries

70 (29.3)

Yes

172 (72)
67 (28)

Vaginal

Caesarean section

Delivery mode (N (%))

169 (70.7)

No

Obstetric risk h (N (%))

98 (41)

Nulliparous

Parity (N (%))

23 (9.6)

No

Cohabitation with baby’s father (N (%))

110 (46)

White Non-Hispanic

Maternal ethnicity (N (%))

28 (11.7)

Some college, vocational, or AA degree

Author Manuscript

High school

36 (30.3)

83 (69.7)

43 (36.1)

76 (63.9)

2 (1.7)

7 (5.9)

17 (14.3)

44 (37)

70 (58.8)

49 (41.2)

106 (89.1)

13 (10.9)

2 (1.7)

3 (2.5)

10 (8.4)

18 (15.1)

35 (29.4)

51 (42.9)

1 (0.8)

21 (17.6)

31 (26.1)

52 (43.7)

12 (10.1)

31 (25.8)

89 (74.2)

27 (22.5)

93 (77.5)

1 (0.8)

6 (5)

12 (10)

52 (43.3)

71 (59.2)

49 (40.8)

110 (91.7)

10 (8.3)

2 (1.7)

5 (4.2)

12 (10)

13 (10.8)

28 (23.3)

59 (49.2)

0 (0)

20 (16.7)

34 (28.3)

45 (37.5)

16 (13.3)

Cohort Half 2

Author Manuscript
Cohort Half 1

ns

Xsq=4.7 *

ns

ns

ns

Half 1 vs Half 2a

27 (31.4)

59 (68.6)

26 (30.2)

60 (69.8)

2 (2.3)

7 (8.1)

13 (15.1)

35 (40.7)

57 (66.3)

29 (33.7)

70 (81.4)

16 (18.6)

1 (1.2)

4 (4.7)

8 (9.3)

15 (17.4)

19 (22.1)

39 (45.3)

1 (1.2)

10 (11.6)

22 (25.6)

38 (44.2)

11 (12.8)

Depressed subset

ns

ns

ns

Xsq=10.9 ***

ns

Euthymic vs Depresseda

Author Manuscript

Full cohort
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Author Manuscript
20 (8.4)

Yes

15 (6.3)

Yes

129 (54)

Male

152 (63.6)
12 (5)

Yes

NA
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6 (5)

75 (62.5)

38 (31.7)

61 (50.8)

59 (49.2)

7 (5.8)

112 (93.3)

9 (7.5)

111 (92.5)

CESD-SF: Center for Epidemiologic Studies Depression Scale (Radloff, 1991) Short Form (Santor & Coyne, 1997)

ns

ns

ns

ns

ns

ns

ns

ns

Euthymic vs Depresseda

Women who met one or both traditional criteria for risk of depression based upon EPDS cutoff of 10/40 (Earls, 2010) and CESD-SF cutoff of 5/36 (Irwin, Artin, & Oxman, 1999; Martens et al., 2006).

5 (5.8)

54 (62.8)

27 (31.4)

46 (53.5)

40 (46.5)

4 (4.7)

82 (95.3)

11 (12.8)

75 (87.2)

Depressed subset

Preterm delivery is defined as delivery earlier than 37 weeks’ gestation.

i

Obstetric risk is defined as having any of the following gestational complications: hypertension; diabetes; severe infection; vaginal bleeding; anemia; oligohydramnios; placental abruption.

h

History of mental illness defined as previous to this pregnancy they had ever been diagnosed with a psychological or emotional problem (N=10), had a serious mental illness, emotional problem, or
nervous breakdown (N=5), if they had ever stayed overnight or longer in a hospital or treatment facility because of any mental or emotional problem (N=2).

g

Antidepressant medications at postpartum timepoint included Paxil (N=1), Prozac (N=3), Wellbutrin (N=3), Zoloft (N=3), one of the latter also using Celexa, and at the after-postpartum timepoint Lexapro
(N=1), Prozac (N=1), Zoloft (N=2), Celexa (N=1), Wellbutrin (N=3), and one of the latter also using Paxil.

Women who met one or both traditional criteria for risk of depression based upon EPDS cutoff of 12/40 (Earls, 2010) and CESD-SF cutoff of 5/36 (Irwin et al., 1999; Martens et al., 2006).

e

d

EPDS: Edinburgh Postnatal Depression Scale (Cox, Holden, & Sagovsky, 1987)

c

f

6 (5)

75 (63)

38 (31.9)

68 (57.1)

51 (42.9)

7 (5.9)

112 (94.1)

11 (9.2)

108 (90.8)

Half 1 vs Half 2a

The columns titled “Half 1 vs Half 2” and “Euthymic vs Depressed” present the results of significant t-tests and chi-squared tests with Yates’ correction.

b

a

Data depict information for the postpartum timepoint unless otherwise noted.

75 (31.4)

No

Breastfeeding (N (%))

110 (46)

Female

Infant sex (N (%))

224 (93.7)

No

Low birthweightj (N (%))

219 (91.6)

No

Preterm deliveryi (N (%))

Cohort Half 2

Author Manuscript
Cohort Half 1

Author Manuscript

Full cohort

Fox et al.
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Author Manuscript
p<0.0001; ns=not significant

p<0.001;

****

***

p<0.01;

**

p <0.05;

*

+
p < 0.10;

NA=not available;

Low birthweight is defined as lower than 10th percentile weight for gestational age and sex at birth.

Author Manuscript

j
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x

x

Positive mood reactivity

x

x

x

x

x

Inability to stay asleep

Oversleeping/hypersomnia

Inability to fall asleep/insomnia

x

x

Anhedonia/diminished capacity for pleasure

Loss of interest

x

Increased appetite
x

x

Decreased appetite

x
x

Weight gain
x

x

Weight loss

Indecisiveness

x

x

x

x

x

x

x

x

x

Inability to focus/concentrate
x

x

Diminished mental sharpness/ability to think

x

x

x

x

Agitated

x

x

x

x

x

x

x

x

Thoughts or desires of self-harm

Psychomotor agitation

Psychomotor retardation/feeling slowed down

Worthlessness/loss of confidence

x

x

x

x

x

x

x

x

x

SDQl

Guilt

x

x

IDSk

x

x

x

ICD-10 j

Sleepiness

Loss of energy

Fatigue

Sadness

DSM-5 i

x

x

x

x

x

x

DSSm

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

BDIn

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

CIDIo

Fatigue

Phys Symc

CESDa

CESDa

Phys Symc

My sleep was restless.

I enjoyed life (reverse scored)

Poor appetite

I had trouble keeping my mind on what I was doing

I was bothered by things that don’t usually bother me

CESDa

CESDa

The thought of harming myself has occurred to me

I felt that everything I did was an effort

EPDSd

CESDa

I have blamed myself unnecessarily when things went
wrong

I felt sad

CESDa

EPDSd

Item with which we measure symptom

Scale with which
we measure
symptom

Author Manuscript

Depression symptoms full list and subset assessed in this study

Author Manuscript

Table 2
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Author Manuscript
x

Sudden anger attacks
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x

Diminished sexual interest

x

x

Diurnal mood pattern

x

x

x

Panic/phobic

Interpersonal sensitivity

x

Ability to work/study/function at home

x

x

Diminished sexual functioning

x

Ability to find words

x

x

Self-dislike

Memory problems

x

Punishment feelings

x

x

x

BDIn

x

x

x

x

DSSm

Past failure

Lack of control/helplessness

Diminished social functioning

x

x

Crying

Anger

x

Sad affect display

x

x

GI problems

x
x

x

x

x

Heavy limbs/weighted down

Pains/aches

x

x

Irritable

Heart palpitations

x

Anxiety

x

x

x

Pessimism

SDQl

x

Author Manuscript

Negative mood reactivity

IDSk

x

x

x

x

x

x

x

CIDIo

How often have you been able to control irritations in
your life?

PSSe

Constipation, Diarrhea, Heartburn, Nausea, Vomitingg
I felt that I could not shake off the blues even with
help from my family and friends
I have been so unhappy that I have been crying
I feel like breaking things
I feel angry

Phys Symc
CESDa
EPDSd
STAXIf
STAIb

Back pain, Joint pain, Muscle pain, Leg paing

I have been anxious or worried for no good reason

EPDSd

Phys Symc

I am presently worrying over possible misfortunes

STAIb

Palpitations

How often have you been upset because of something
that happened unexpectedly

PSSe

Phys Symc

Item with which we measure symptom

Scale with which
we measure
symptom

Author Manuscript

ICD-10 j

Author Manuscript

DSM-5 i
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x

EPDS: Edinburgh Postnatal Depression Scale (Cox, Holden, & Sagovsky, 1987)

STAXI: State Trait Anger Expression Inventory (Fuqua et al., 1991)

PSS: Perceived Stress Scale (Cohen, Kamarck, & Mermelstein, 1983)

x

x
x

BDIn

x

x

CIDIo

Scale with which
we measure
symptom
Item with which we measure symptom
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Items that encompass more than one symptom (as defined by other scales that separate that item) are signified by a merged cell. The DSM-5 defines MDD as at least a two-week period of low mood or loss
of pleasure, with no history of mania, alongside other daily symptoms including low appetite or weight loss, insomnia or hypersomnia, psychomotor retardation or agitation, fatigue, feelings of
worthlessness or inappropriate guilt, diminished ability to think or concentrate, and/or suicidal behavior or ideation. ICD-10 proposes a similar definition involving at least one of these symptoms: persistent
sadness or low mood, loss of interests or pleasure, fatigue or low energy, most days, most of the time for at least 2 weeks, alongside the following for a total of at least four symptoms: reduced enjoyment,

CIDI: WHO-Composite International Diagnostic Interview (Wittchen, 1994)

o

BDI: Beck Depression Inventory (Beck, Steer, & Carbin, 1988)

n

DSS: Depressive Symptoms Scale (Keller & Nesse, 2006)

SDQ: Symptoms of Depression Questionnaire (Pedrelli et al., 2014)

m

l

k
IDS: Inventory of Depressive Symptomatology (Rush, Carmody, & Reimitz, 2000)

j
ICD-10: International Statistical Classification of Diseases and Related Health Problems 10th Revision (World_Health_Organization, 2016)

i
DSM-5: Diagnostic and Statistical Manual of Mental Disorders Fifth edition (American_Psychiatric_Association, 2003)

Two depression symptoms were characterized by more than one item. “Pains and aches” was assessed by separate questions about back, joint, muscle, and leg pains. “GI (stomach or bowel) symptoms”
was assessed by separate questions about constipation, diarrhea, heartburn, nausea, and vomiting. Each of these items was assessed from a questionnaire in which women described their frequency of each
experience on Likert scales ranging from 1=never to 5=four or more times per week. These items were recoded as binary, with 0=never and 1=one or more times per week. Then, the sum was taken so that
“Pain and aches” scores ranged from 0–4 and reflected how many kinds of pains women experienced per week, while “GI (stomach or bowel) symptoms” scores ranged from 0–5 and reflected how many
kids of GI problems women experienced per week. Subsequently, these variables along with all symptom variables were unitized.

g

f

Thoughts or desires of suicide

Phys Sym: Physical symptoms questionnaire for pregnancy and postpartum

d

e

x

STAI: State-Trait Anxiety Inventory (Kvaal, Ulstein, Nordhus, & Engedal, 2005)

b

c

x

x

Thoughts or desires of death

x

Desire for social support

DSSm

Rumination

x

SDQl

CESD: Center for Epidemiologic Studies Depression Scale (Radloff, 1991). In this study the CESD Short Form (SF) (Santor & Coyne, 1997) was administered.

a

Author Manuscript

Unresponsive mood/flat affect

Author Manuscript
IDSk

Author Manuscript

ICD-10 j

Author Manuscript

DSM-5 i
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Author Manuscript

Author Manuscript

Author Manuscript

Author Manuscript

reduced interest, reduced concentration, fatigue, tiredness, guilt, worthlessness, reduced self-esteem, and/or somatic symptoms such as loss of pleasure, sleep dysregulation, psychomotor retardation or
agitation, loss of appetite, weight loss, and/or loss of libido.
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Table 3

Author Manuscript

Factor structure from exploratory factor analysis of postpartum depression symptoms
Factor

Item

Loading on factor

Factor 1, “Worry”

Anxiety

1.000

Guilt

0.418

Anger attacks

0.906

Anger

0.458

Agitated

0.635

Irritability

0.551

Anhedonia

0.515

Fatigue

0.497

Sad

0.471

Inability to stay asleep

0.304

Psychomotor retardation

0.300

Factor 4, “Appetite”

Low appetite

1.000

Factor 5, “Somatic/Cognitive”

GI problems

0.718

Pain

0.597

Inability to focus

0.427

Palpitations

0.378

Sad affect display

0.601

Crying

0.540

Thoughts of self harm

0.421

none

Negative reactivity

none

none

Pessimism

none

Factor 2, “Anger”

Factor 3, “Emotional/Circadian/Energetic Dysregulation”

Author Manuscript

Factor 6, “Distress display”

Author Manuscript
Author Manuscript
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Author Manuscript
1-factor

6-factor

1-factor

6-factor

1-factor

6-factor

Is 6-factor better fit than 1-factor model?

Clinical depression postpartum

Is 6-factor better fit than 1-factor model?

After-postpartum

Is 6-factor better fit than 1-factor model?

Postpartum half #2

Mod8

Mod7

Mod6

Mod5

Mod4

Mod3

Mod2

0.065
Lower ✓

1.364
Lower ✓

0.052

Lower ✓

Lower ✓
1.237

0.090

2.066

0.077

Lower ✓

Lower ✓
1.786

0.073

1.635

0.072

Lower ✓

Lower ✓
1.621

0.088

0.062

1.924

1.454

RMSEAb

Higher ✓

0.751

0.853

Higher ✓

0.783

0.855

Higher ✓

0.871

0.885

Higher ✓

0.708

0.870

CFIc

Higher ✓

0.720

0.818

Higher ✓

0.756

0.820

Higher ✓

0.854

0.858

Higher ✓

0.671

0.839

TLId

Higher ✓

0.472

0.566

Higher ✓

0.658

0.731

Higher ✓

0.729

0.756

Higher ✓

0.551

0.692

NFIe

Lower ✓

0.086

0.079

Lower ✓

0.084

0.073

Lower ✓

0.071

0.068

Lower ✓

0.091

0.078

SRMRf

χ2 diff=28.081
p=0.014 *

χ2 diff=67.515
p=0.000 ****

χ2 diff=24.796
p=0.037 *

χ2 diff=91.844 p=0.000 ****

χ2 difference test
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p<0.05

*

Inspection of the standardized residual correlation tables revealed no patterns of fit problems, as no more than 2 of the 18 correlations for any individual item were significant at the 0.05 level. Modification
indices were all small (<25.00) indicating no need to alter the models’ designs.

The standardized root mean square residual (SRMR) (Joreskog & Sorbom, 1981) is an absolute fit index for which lower values indicate better fit. Values ≤ .08 indicate good fit (L.-t. Hu & Bentler, 1998;
L. t. Hu & Bentler, 1999), disqualifying Mod2,6,8.

f

The Normed Fit Index (NFI) is an incremental fit measure for which larger values indicate better fit (Bentler & Bonett, 1980).

e

d
The Tucker-Lewis index (TLI) is a relative fit index, for which higher values indicate better fit (Tucker & Lewis, 1973).

c
The comparative fit index (CFI) is another noncentrality-based index, for which higher values indicate better fit (Bentler, 1990). Values > 0.80 are considered acceptable (Sharma, Mukherjee, Kumar, &
Dillon, 2005), disqualifying Mod2,6,8.

The root mean square error of approximation (RMSEA) is a noncentrality-based index, for which lower values indicate better fit. RMSEA values < 0.05 indicates close fit (Steiger, 1990), and values < 0.08
are considered acceptable (Browne, Cudeck, Bollen, & Long, 1993; Cangur & Ercan, 2015; Hooper, Coughlan, & Mullen, 2008), disqualifying Mod2 and Mod6.

b

Relative chi-square is calculated as the chi-square statistic divided by the degrees of freedom. Lower values indicate better fit. Values < 2 are considered acceptable (Ullman, 2001), disqualifying Mod6.

a

1-factor

Mod1

6-factor

Is 6-factor better fit than 1-factor model?

Postpartum half #1

Model #

Model structure

Relative chisqa

Author Manuscript

Cohort

Author Manuscript

Confirmatory factor analysis fit indices

Author Manuscript
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p<0.001

Page 27

***

**

p<0.01
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Author Manuscript
Author Manuscript
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